Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for Orthostatic hypotension (postural hypotension)

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Phase 3 Extension Study of TD-9855 for Treating snOH in Subjects with Primary Autonomic Failure

    Rochester, MN

  2. Droxidopa / Pyridostigmine in Orthostatic Hypotension

    Rochester, MN

  3. A Study to Evaluate the Clinical Effect of TD-9855 for Treating Symptomatic Neurogenic Orthostatic Hypotension (snOH) in Subjects With Primary Autonomic Failure

    Rochester, MN

  4. A Study to Evaluate the Durability of TD-9855 for Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure

    Rochester, MN

  5. 3,4-diaminopyridine (3,4-DAP) use in Patients with Orthostatic Hypotension and Postural Tachycardia Syndrome

    Rochester, MN

  6. A Study to Compare the Mayo Orthostatic Symptom Scale (MOSS) and Orthostatic Hypotension Daily Activities Scale (OHDAS)

    Rochester, MN

.

Mayo Clinic Footer